# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Analysts mention Nasdaq, Salesforce, UnitedHealth and TJX on CNBC's Halftime Report Final Trades.
B of A Securities analyst Brad Sills maintains Salesforce (NYSE:CRM) with a Buy and raises the price target from $288 to $316.
Salesforce is anticipated to release 2024 fiscal year second quarter earnings on August 28 after the market closes.